2014
DOI: 10.4103/0970-1591.142067
|View full text |Cite
|
Sign up to set email alerts
|

Role of robot-assisted radical prostatectomy in the management of high-risk prostate cancer

Abstract: We aimed to evaluate the role of robot-assisted radical prostatectomy (RARP) in the management of high-risk prostate cancer (PCa), with a focus on oncological, functional and perioperative outcomes. Further, we also aimed to briefly describe our novel modification to conventional RARP that allows immediate organ retrieval and examination for intra-operative surgical margin assessment. A literature search of PubMed was performed for articles on the management of high-risk PCa. Papers written in English and conc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
9
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 48 publications
2
9
0
2
Order By: Relevance
“…The overall continence rate among high-risk groups varies from 84% to 96% in various study groups. [ 5 ] Our rate is comparable with these results. This gives credence to the fact that high-risk group alone does not predispose to incontinence.…”
Section: Discussionsupporting
confidence: 91%
See 3 more Smart Citations
“…The overall continence rate among high-risk groups varies from 84% to 96% in various study groups. [ 5 ] Our rate is comparable with these results. This gives credence to the fact that high-risk group alone does not predispose to incontinence.…”
Section: Discussionsupporting
confidence: 91%
“…had postulated that the high-risk group undergoing RARP had a higher incidence of complications. [ 5 20 ] In our series, none of the patients had Clavien 3 or more complications.…”
Section: Discussionmentioning
confidence: 54%
See 2 more Smart Citations
“…However, given the relative novelty of RARP, many surgeons are reluctant to use this procedure in patients with clinically high-risk PCa [9,10]. Consequently, only a handful of groups have reported on their experience of RARP in high-risk PCa patients, and even these groups have only reported on shortterm and perioperative outcomes [11,12]. To date, long-term cancer control outcomes following RARP in men with highrisk PCa remain poorly addressed.…”
Section: Introductionmentioning
confidence: 99%